Pathogenesis-directed therapy of methylphenidate-induced oxidative heart damage in rats

ArticleAçık Erişim

Özet

Aim: The current study aimed to investigate the protective effects of adenosine triphosphate (ATP), metyrosine, and melatonin on possible methylphenidate cardiotoxicity in rats using biochemical and histopathological methods. Methods: Thirty rats were separated into five groups: healthy (HG), methylphenidate (MP), ATP + methylphenidate (ATMP), metyrosine + methylphenidate (MSMP), and melatonin + methylphenidate (MLMP). ATP (5 mg/kg) was given intraperitoneally once daily, metyrosine (50 mg/kg) orally twice daily, and melatonin (10 mg/kg) orally once daily. Methylphenidate (10 mg/kg) was administered orally once daily for 1 h after ATP, metyrosine and melatonin. The protocol was repeated for 30 days. Subsequently, blood samples were taken from the tail veins of the animals to measure adrenaline, noradrenaline, dopamine, troponin I (TP I) and creatine kinase MB (CK-MB) levels; the animals were then euthanized and the heart tissues were extracted. Tissues were analyzed for malondialdehyde (MDA), total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) and histopathologically. Results: In MP group, MDA, adrenaline, noradrenaline, dopamine, TP I, and CK-MB levels increased (p < 0.001) and tGSH, SOD, and CAT levels decreased (p < 0.001) compared to HG, and histopathologic damage developed. Oxidant levels were lower and antioxidant levels were higher in ATMP, MSMP, and MLMP groups compared to MP group (p < 0.001). Catecholamine levels were measured lower in the MSMP group compared to the MP group (p < 0.001). TP I and CK-MB levels were lower in ATMP, MSMP and MLMP groups compared to MP (p < 0.05), with the lowest being in rats given ATP (p < 0.001). ATP, melatonin, and metirozin applications were effective to different degrees in preventing histopathological changes. Conclusion: This study may guide clinical trials using ATP and melatonin to prevent methylphenidate-induced myocardial injury. Copyright © 2025 Emir, Bulut, Suleyman, Mammadov, Yucel, Cicek, Yazici, Altuner, Gunay and Suleyman.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11586Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.3389/fphar.2024.1503032Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorEmir, Izzet
dc.contributor.authorBulut, Seval
dc.contributor.authorSuleyman, Bahadır
dc.contributor.authorMammadov, Renad
dc.contributor.authorYucel, Nurinisa
dc.contributor.authorCicek, Betul
dc.contributor.authorYazici, Gulce Naz
dc.contributor.authorAltuner, Durdu
dc.contributor.authorGunay, Murat
dc.contributor.authorSuleyman, Halis
dc.date.accessioned2026-10-18T20:26:37.016966191Z
dc.date.available2026-10-18T20:26:37.016966191Z
dc.date.issued2024
dc.description.abstractAim: The current study aimed to investigate the protective effects of adenosine triphosphate (ATP), metyrosine, and melatonin on possible methylphenidate cardiotoxicity in rats using biochemical and histopathological methods. Methods: Thirty rats were separated into five groups: healthy (HG), methylphenidate (MP), ATP + methylphenidate (ATMP), metyrosine + methylphenidate (MSMP), and melatonin + methylphenidate (MLMP). ATP (5 mg/kg) was given intraperitoneally once daily, metyrosine (50 mg/kg) orally twice daily, and melatonin (10 mg/kg) orally once daily. Methylphenidate (10 mg/kg) was administered orally once daily for 1 h after ATP, metyrosine and melatonin. The protocol was repeated for 30 days. Subsequently, blood samples were taken from the tail veins of the animals to measure adrenaline, noradrenaline, dopamine, troponin I (TP I) and creatine kinase MB (CK-MB) levels; the animals were then euthanized and the heart tissues were extracted. Tissues were analyzed for malondialdehyde (MDA), total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) and histopathologically. Results: In MP group, MDA, adrenaline, noradrenaline, dopamine, TP I, and CK-MB levels increased (p < 0.001) and tGSH, SOD, and CAT levels decreased (p < 0.001) compared to HG, and histopathologic damage developed. Oxidant levels were lower and antioxidant levels were higher in ATMP, MSMP, and MLMP groups compared to MP group (p < 0.001). Catecholamine levels were measured lower in the MSMP group compared to the MP group (p < 0.001). TP I and CK-MB levels were lower in ATMP, MSMP and MLMP groups compared to MP (p < 0.05), with the lowest being in rats given ATP (p < 0.001). ATP, melatonin, and metirozin applications were effective to different degrees in preventing histopathological changes. Conclusion: This study may guide clinical trials using ATP and melatonin to prevent methylphenidate-induced myocardial injury. Copyright © 2025 Emir, Bulut, Suleyman, Mammadov, Yucel, Cicek, Yazici, Altuner, Gunay and Suleyman.
dc.identifier.doi10.3389/fphar.2024.1503032
dc.identifier.eissn1663-9812
dc.identifier.issn1663-9812
dc.identifier.pmcidPMC11739286
dc.identifier.pmid39830352
dc.identifier.scopus2-s2.0-85214991150
dc.identifier.startpage1503032
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11586
dc.identifier.volume15
dc.identifier.wosWOS:001398456400001
dc.language.isoen
dc.publisherFrontiers Media SA
dc.relation.ispartofFrontiers in Pharmacology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectadenosine triphosphate
dc.subjectmelatonin
dc.subjectmethylphenidate
dc.subjectmetyrosine
dc.subjectoxidative stress
dc.subjectcatalase
dc.subjectcatecholamine
dc.subjectcreatine kinase MB
dc.subjectdopamine
dc.subjectepinephrine
dc.subjectglutathione
dc.subjectmalonaldehyde
dc.subjectmetirosine
dc.subjectnoradrenalin
dc.subjectsuperoxide dismutase
dc.subjecttroponin I
dc.subjectanimal experiment
dc.subjectanimal tissue
dc.subjectArticle
dc.subjectbiochemical analysis
dc.subjectblood sampling
dc.subjectcardiotoxicity
dc.subjectchemical analysis
dc.subjectcontrolled study
dc.subjectenzyme activity
dc.subjectenzyme linked immunosorbent assay
dc.subjectheart injury
dc.subjecthigh performance liquid chromatography
dc.subjecthistopathology
dc.subjectnonhuman
dc.titlePathogenesis-directed therapy of methylphenidate-induced oxidative heart damage in rats
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus3
rdl.citation.wos3
rdl.departmentDepartment of Cardiovascular Surgery, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Türkiye. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Türkiye. | Pharmacy Services Program, Vocational School of Health Services, Erzincan Binali Yildirim University, Erzincan, Türkiye. | Department of Physiology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Türkiye. | Department of Histology and Embryology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Türkiye. | Biochemistry Laboratory, Erzincan Mengücek Gazi Training and Research Hospital, Erzincan Binali Yildirim University, Erzincan, Türkiye.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)